Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial

Frank Siebenhaar, Sabine Altrichter, Hanna Bonnekoh, Tomasz Hawro, Marlena Hawro, Edward G. Michaelis, Andrea M. Kantor, Alan T. Chang, Bradford A. Youngblood, Bhupinder Singh, Henrik S. Rasmussen, Marcus Maurer^*

^*Corresponding author for this work